Label: LOVAZA- omega-3-acid ethyl esters capsule
- NDC Code(s): 80725-420-12
- Packager: Waylis Therapeutics LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated February 5, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use LOVAZA safely and effectively. See full prescribing information for LOVAZA. LOVAZA (omega-3-acid ethyl esters capsules), for oral ...
-
Table of ContentsTable of Contents
-
1 INDICATIONS AND USAGELOVAZA (omega-3-acid ethyl esters) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (greater than or equal to 500 mg/dL ...
-
2 DOSAGE AND ADMINISTRATIONAssess TG levels carefully before initiating therapy. Identify other causes (e.g., diabetes mellitus, hypothyroidism, medications) of high TG levels and manage as appropriate [see Indications and ...
-
3 DOSAGE FORMS AND STRENGTHSLOVAZA (omega-3-acid ethyl esters) capsules are supplied as 1-gram transparent, soft-gelatin capsules filled with light-yellow oil and bearing the designation "LOVAZA".
-
4 CONTRAINDICATIONSLOVAZA is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to LOVAZA or any of its components.
-
5 WARNINGS AND PRECAUTIONS5.1 Monitoring: Laboratory Tests - In patients with hepatic impairment, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels should be monitored periodically during therapy ...
-
6 ADVERSE REACTIONS6.1 Clinical Trials Experience - Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly ...
-
7 DRUG INTERACTIONS7.1 Anticoagulants or Other Drugs Affecting Coagulation - Some trials with omega-3-acids demonstrated prolongation of bleeding time. The prolongation of bleeding time reported in these trials has ...
-
8 USE IN SPECIFIC POPULATIONS8.1 Pregnancy - Risk Summary - The available data from published case reports and the pharmacovigilance database on the use of LOVAZA in pregnant women are insufficient to identify a ...
-
11 DESCRIPTIONLOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty ...
-
12 CLINICAL PHARMACOLOGY12.1 Mechanism of Action - The mechanism of action of LOVAZA is not completely understood. Potential mechanisms of action include inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase ...
-
13 NONCLINICAL TOXICOLOGY13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - In a rat carcinogenicity study with oral gavage doses of 100, 600, and 2,000 mg/kg/day, males were treated with omega-3-acid ethyl ...
-
14 CLINICAL STUDIES14.1 Severe Hypertriglyceridemia - The effects of LOVAZA 4 grams per day were assessed in 2 randomized, placebo-controlled, double-blind, parallel-group trials of 84 adult subjects (42 on LOVAZA ...
-
16 HOW SUPPLIED/STORAGE AND HANDLINGLOVAZA (omega-3-acid ethyl esters) capsules are supplied as 1-gram, transparent, soft-gelatin capsules filled with light-yellow oil and bearing the designation "LOVAZA". Bottles of 120: NDC ...
-
17 PATIENT COUNSELING INFORMATIONAdvise the patient to read the FDA-approved patient labeling (Patient Information). Information for Patients - LOVAZA should be used with caution in patients with known sensitivity or allergy ...
-
SPL UNCLASSIFIED SECTIONManufactured for: Waylis Therapeutics LLC - Rahway, NJ 07065
-
PATIENT PACKAGE INSERTPATIENT INFORMATION - LOVAZA (LO-VA-ZA) (omega-3-acid ethyl esters - capsules) This Patient Information has been approved by the U.S. Food and Drug Administration.Revised 11/2024 - What is ...
-
PRINCIPAL DISPLAY PANEL - 1 gram Bottle LabelNDC 80725-420-12 - Lovaza® (omega-3-acid - ethyl esters) Capsules - 1 gram* Swallow capsules whole. Rx only - 120 Capsules - Waylis - THERAPEUTICS
-
INGREDIENTS AND APPEARANCEProduct Information